2,101
Views
101
CrossRef citations to date
0
Altmetric
Research Paper

Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment

, , , , , , , , , , , , , , , , , & show all
Pages 858-870 | Received 19 Dec 2011, Accepted 22 May 2012, Published online: 01 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Daniela Magliulo & Rosa Bernardi. (2018) HIF-α factors as potential therapeutic targets in leukemia. Expert Opinion on Therapeutic Targets 22:11, pages 917-928.
Read now
Ping Liu, Haijun Zhang, Xue Wu, Liting Guo, Fei Wang, Guohua Xia, Baoan Chen, HaiXiang Yin, Yonglu Wang & Xueming Li. (2016) Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells. OncoTargets and Therapy 9, pages 5049-5059.
Read now
Kevin Rouault-Pierre, Ashley Hamilton & Dominique Bonnet. (2016) Effect of hypoxia-inducible factors in normal and leukemic stem cell regulation and their potential therapeutic impact. Expert Opinion on Biological Therapy 16:4, pages 463-476.
Read now
Yu-Yang Pang, Ting Wang, Fang-Yuan Chen, Ying-Li Wu, Xia Shao, Fei Xiao, Hong-Hui Huang, Hua Zhong & Ji-Hua Zhong. (2015) Glycolytic inhibitor 2-deoxy-d-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1α and c-MYC. Leukemia & Lymphoma 56:6, pages 1821-1830.
Read now
Vanessa S. Silveira, Bruno M. R. Freire, Kleiton S. Borges, Augusto F. Andrade, Gustavo A. V. Cruzeiro, João Paulo J. Sabino, Mogens Lesner Glass, José Andres Yunes, Silvia Regina Brandalise, Luiz Gonzaga Tone & Carlos Alberto Scrideli. (2014) Hypoxia-related gene expression profile in childhood acute lymphoblastic leukemia: prognostic implications. Leukemia & Lymphoma 55:8, pages 1751-1757.
Read now
Wei Zhang, Bao-an Chen, Jun-fei Jin, You-ji He & Yi-qi Niu. (2013) Involvement of c-Jun N-terminal kinase in reversal of multidrug resistance of human leukemia cells in hypoxia by 5-bromotetrandrine. Leukemia & Lymphoma 54:11, pages 2506-2516.
Read now

Articles from other publishers (95)

Alessia Ostini & Mirna Mourtada-Maarabouni. (2023) Investigation into the Role of Long-Non-Coding RNA MIAT in Leukemia. Non-Coding RNA 9:4, pages 47.
Crossref
Swati S. Bhasin, Beena E. Thomas, Ryan J. Summers, Debasree Sarkar, Hope Mumme, William Pilcher, Mohamed Emam, Sunil S. Raikar, Sunita I. Park, Sharon M. Castellino, Douglas K. Graham, Manoj K. Bhasin & Deborah DeRyckere. (2023) Pediatric T-cell acute lymphoblastic leukemia blast signature and MRD associated immune environment changes defined by single cell transcriptomics analysis. Scientific Reports 13:1.
Crossref
Cindy Mayerli Arévalo, Nataly Cruz-Rodriguez, Sandra Quijano & Susana Fiorentino. (2023) Plant-derived extracts and metabolic modulation in leukemia: a promising approach to overcome treatment resistance. Frontiers in Molecular Biosciences 10.
Crossref
Igor Pottosin, Miguel Olivas-Aguirre & Oxana Dobrovinskaya. (2023) In vitro simulation of the acute lymphoblastic leukemia niche: a critical view on the optimal approximation for drug testing. Journal of Leukocyte Biology 114:1, pages 21-41.
Crossref
Hanieh Kolahi Azar, Aylar Imanpour, Hanieh Rezaee, Fatemeh Ezzatifar, Zeinab Zarei‐Behjani, Mohammadreza Rostami, Mahmoud Azami, Nima Behestizadeh & Nima Rezaei. (2023) Mesenchymal stromal cells and CAR‐T cells in regenerative medicine: The homing procedure and their effective parameters . European Journal of Haematology.
Crossref
Rana M. Hanafy, Soheir R. Demian, Lobna A. Abou-Shamaa, O. Ghallab & Eman M. Osman. (2023) In-vitro Modulation of mTOR-HIF-1α Axis by TLR7/8 Agonist (Resiquimod) in B-Chronic Lymphocytic Leukemia. Indian Journal of Hematology and Blood Transfusion.
Crossref
Mingzhou Guo, Yang Niu, Min Xie, Xiansheng Liu & Xiaochen Li. (2023) Notch signaling, hypoxia, and cancer. Frontiers in Oncology 13.
Crossref
Anastasia M. Hughes, Vincent Kuek, Joyce Oommen, Grace-Alyssa Chua, Maria van Loenhout, Sebastien Malinge, Rishi S. Kotecha & Laurence C. Cheung. (2023) Characterization of mesenchymal stem cells in pre-B acute lymphoblastic leukemia. Frontiers in Cell and Developmental Biology 11.
Crossref
Jérémie Rouger-Gaudichon, Elie Cousin, Hélène Jakobczyk, Lydie Debaize, Anne-Gaëlle Rio, Anne Forestier, Marie-Pierre Arnaud, Arnaud Villacreces, Vincent Praloran, Rodrigo Jacamo, Marie-Dominique Galibert, Marie-Bérengère Troadec & Virginie Gandemer. (2022) Hypoxia regulates CD9 expression and dissemination of B lymphoblasts. Leukemia Research 123, pages 106964.
Crossref
Bill Harris, Sana Saleem, Natalie Cook & Emma Searle. (2022) Targeting hypoxia in solid and haematological malignancies. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Yiqing Tian, Jian Fang, Fanpeng Zeng, Yongqiang Chen, Yunfeng Pei, Feng Gu, Chen Ding, Guoping Niu & Bing Gu. (2022) The role of hypoxic mesenchymal stem cells in tumor immunity. International Immunopharmacology 112, pages 109172.
Crossref
You Mie Lee. (2022) RUNX Family in Hypoxic Microenvironment and Angiogenesis in Cancers. Cells 11:19, pages 3098.
Crossref
Hao Wang, Lingling Chi, Fuqiang Yu, Hongling Dai, Xiaojie Si, Chao Gao, Zhengjie Wang, Limin Liu, Jiaxin Zheng, Yu Ke, Hongmin Liu & Qiurong Zhang. (2022) The overview of Mitogen-activated extracellular signal-regulated kinase (MEK)-based dual inhibitor in the treatment of cancers. Bioorganic & Medicinal Chemistry 70, pages 116922.
Crossref
Daniela Magliulo & Rosa Bernardi. (2022) Hypoxic stress and hypoxia-inducible factors in leukemias. Frontiers in Oncology 12.
Crossref
Taja Železnik Ramuta & Mateja Erdani Kreft. (2022) Mesenchymal Stem/Stromal Cells May Decrease Success of Cancer Treatment by Inducing Resistance to Chemotherapy in Cancer Cells. Cancers 14:15, pages 3761.
Crossref
Eun Jung Lee, Kyung Do Han, Sung-Yong Kim, Jeffrey D. Suh, Jin Kook Kim & Jae Hoon Cho. (2022) Increased incidence of leukemia in patients with obstructive sleep apnea: Results from the national insurance claim data 2007–2014. Sleep Medicine 96, pages 113-118.
Crossref
Beibei Qu, Xiuhua Han, Lan Zhao, Feifei Zhang & Qingmei Gao. (2022) Relationship of HIF‑1α expression with apoptosis and cell cycle in bone marrow mesenchymal stem cells from patients with myelodysplastic syndrome. Molecular Medicine Reports 26:1.
Crossref
Anastasia M. Hughes, Vincent Kuek, Rishi S. Kotecha & Laurence C. Cheung. (2022) The Bone Marrow Microenvironment in B-Cell Development and Malignancy. Cancers 14:9, pages 2089.
Crossref
Gregg L. Semenza. (2022) Breakthrough science: hypoxia-inducible factors, oxygen sensing, and disorders of hematopoiesis. Blood 139:16, pages 2441-2449.
Crossref
Wen-Chin Lee, Chien-Hua Chiu, Tian-Huei Chu & Yu-Shu Chien. (2022) WT1: The Hinge Between Anemia Correction and Cancer Development in Chronic Kidney Disease. Frontiers in Cell and Developmental Biology 10.
Crossref
Daoping Zhou, Juan Gu, Yueping Wang, Bing Luo, Mei Feng & Xuedong Wang. (2022) Long noncoding RNA CCAT2 reduces chemosensitivity to 5‐fluorouracil in breast cancer cells by activating the mTOR axis. Journal of Cellular and Molecular Medicine 26:5, pages 1392-1401.
Crossref
Gabriela Antonio-Andres, Gustavo U. Martinez-Ruiz, Mario Morales-Martinez, Elva Jiménez-Hernandez, Estefany Martinez-Torres, Tania V. Lopez-Perez, Laura A. Estrada-Abreo, Genaro Patino-Lopez, Sergio Juarez-Mendez, Víctor M. Davila-Borja & Sara Huerta-Yepez. (2022) Transcriptional Regulation of Yin-Yang 1 Expression through the Hypoxia Inducible Factor-1 in Pediatric Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences 23:3, pages 1728.
Crossref
Bianca A. W. Hoeben, Jeffrey Y. C. Wong, Lotte S. Fog, Christoph Losert, Andrea R. Filippi, Søren M. Bentzen, Adriana Balduzzi & Lena Specht. (2021) Total Body Irradiation in Haematopoietic Stem Cell Transplantation for Paediatric Acute Lymphoblastic Leukaemia: Review of the Literature and Future Directions. Frontiers in Pediatrics 9.
Crossref
Jonathan D. Diedrich, Qian Dong, Daniel C. Ferguson, Brennan P. Bergeron, Robert J. Autry, Maoxiang Qian, Wenjian Yang, Colton Smith, James B. Papizan, Jon P. Connelly, Kohei Hagiwara, Kristine R. Crews, Shondra M. Pruett-Miller, Ching-Hon Pui, Jun J. Yang, Mary V. Relling, William E. Evans & Daniel Savic. (2021) Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networks. Leukemia 35:11, pages 3078-3091.
Crossref
Jinman Zhong, Hang Wu, Xiaoyin Bu, Weiru Li, Shengchun Cai, Meixue Du, Ya Gao & Baohong Ping. (2021) Establishment of Prognosis Model in Acute Myeloid Leukemia Based on Hypoxia Microenvironment, and Exploration of Hypoxia-Related Mechanisms. Frontiers in Genetics 12.
Crossref
Kaori SaitoQi ZhangHaeun YangKotoko Yamatani, Tomohiko Ai, Vivian Ruvolo, Natalia Baran, Tianyu CaiHelen MaRodrigo JacamoVinitha KuruvillaJunichi ImotoSonoko KinjoKazuho IkeoKaori Moriya, Koya SuzukiTakashi Miida, Yong-Mi Kim, Christopher P. Vellano, Michael Andreeff, Joseph R. Marszalek, Yoko Tabe & Marina Konopleva. (2021) Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition. Blood Advances 5:20, pages 4233-4255.
Crossref
Chang Liu, Ying Jin & Zhimin Fan. (2021) The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer. Frontiers in Oncology 11.
Crossref
Vincent Kuek, Anastasia M. Hughes, Rishi S. Kotecha & Laurence C. Cheung. (2021) Therapeutic Targeting of the Leukaemia Microenvironment. International Journal of Molecular Sciences 22:13, pages 6888.
Crossref
Carolina Simioni, Ilaria Conti, Gabriele Varano, Cinzia Brenna, Eva Costanzi & Luca M. Neri. (2021) The Complexity of the Tumor Microenvironment and Its Role in Acute Lymphoblastic Leukemia: Implications for Therapies. Frontiers in Oncology 11.
Crossref
Vassiliki Mpakou, Aris Spathis, Anthi Bouchla, Zoi Tsakiraki, Frieda Kontsioti, Sotirios Papageorgiou, Efthymia Bazani, Konstantinos Gkontopoulos, Thomas Thomopoulos, Irene Glezou, Athanasios Galanopoulos, Argiris Symeonidis, Panagiotis T. Diamantopoulos, Nora‐Athina Viniou, Christina‐Nefeli Kontandreopoulou, Kalliopi Zafeiropoulou, Ioannis Kotsianidis, Eleftheria Lamprianidou, Periklis Foukas, Aristoteles Mpamias & Vasiliki Pappa. (2021) Upregulated hypoxia inducible factor 1α signaling pathway in high risk myelodysplastic syndrome and acute myeloid leukemia patients is associated with better response to 5‐azacytidine—data from the Hellenic myelodysplastic syndrome study group. Hematological Oncology 39:2, pages 231-242.
Crossref
Jay Singh, Sarita Kumari, Mohit Arora, Deepak Verma, Jayanth Kumar Palanichamy, Rajive Kumar, Gunjan Sharma, Sameer Bakhshi, Deepam Pushpam, M. Shadab Ali, Amar Ranjan, Pranay Tanwar, Shyam S. Chauhan, Archna Singh & Anita Chopra. (2021) Prognostic Relevance of Expression of EMP1, CASP1, and NLRP3 Genes in Pediatric B-Lineage Acute Lymphoblastic Leukemia. Frontiers in Oncology 11.
Crossref
Bin Chen, Tuo Cai, Chao Huang, Xueyan Zang, Li Sun, Shuwei Guo, Qianqian Wang, Zhihong Chen, Yuanyuan Zhao, Zhiqiang Han, Rongman Xu, Wenrong Xu, Mei Wang, Bo Shen & Wei Zhu. (2021) G6PD-NF-κB-HGF Signal in Gastric Cancer-Associated Mesenchymal Stem Cells Promotes the Proliferation and Metastasis of Gastric Cancer Cells by Upregulating the Expression of HK2. Frontiers in Oncology 11.
Crossref
Carolina Bernauer, Y. K. Stella Man, Julia C. Chisholm, Elise Y. Lepicard, Simon P. Robinson & Janet M. Shipley. (2020) Hypoxia and its therapeutic possibilities in paediatric cancers. British Journal of Cancer 124:3, pages 539-551.
Crossref
Marjorie C. Delahaye, Kaoutar-Insaf Salem, Jeoffrey Pelletier, Michel Aurrand-Lions & Stéphane J. C. Mancini. (2021) Toward Therapeutic Targeting of Bone Marrow Leukemic Niche Protective Signals in B-Cell Acute Lymphoblastic Leukemia. Frontiers in Oncology 10.
Crossref
Claire L. Pritchard, Shen Y. Heazlewood & Benjamin Cao. 2021. The Cancer Stem Cell Niche. The Cancer Stem Cell Niche 1 34 .
Biting Wang, Zengrui Wu, Jiye Wang, Weihua Li, Guixia Liu, Bo Zhang & Yun Tang. (2020) Insights into the mechanism of Arnebia euchroma on leukemia via network pharmacology approach. BMC Complementary Medicine and Therapies 20:1.
Crossref
Joseph D. Khoury, Mehrnoosh Tashakori, Hong Yang, Sanam Loghavi, Ying Wang, Jing Wang, Sujan Piya & Gautam Borthakur. (2020) Pan-RAF Inhibition Shows Anti-Leukemic Activity in RAS-Mutant Acute Myeloid Leukemia Cells and Potentiates the Effect of Sorafenib in Cells with FLT3 Mutation. Cancers 12:12, pages 3511.
Crossref
Casey D. Stefanski & Jenifer R. Prosperi. (2020) Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response. International Journal of Molecular Sciences 21:21, pages 7844.
Crossref
Xiaoyu Sun, Xuemei Lv, Yuanyuan Yan, Yanyun Zhao, Rong Ma, Miao He & Minjie Wei. (2020) Hypoxia-mediated cancer stem cell resistance and targeted therapy. Biomedicine & Pharmacotherapy 130, pages 110623.
Crossref
Luyao Long, Yehuda G. Assaraf, Zi-Ning Lei, Hongwei Peng, Lin Yang, Zhe-Sheng Chen & Simei Ren. (2020) Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia. Drug Resistance Updates 52, pages 100703.
Crossref
Mateusz Rytelewski, Karine Harutyunyan, Natalia Baran, Saradhi Mallampati, M. Anna Zal, Antonio Cavazos, Jason M. Butler, Sergej Konoplev, Mirna El Khatib, Shane Plunkett, Joseph R. Marszalek, Michael Andreeff, Tomasz Zal & Marina Konopleva. (2020) Inhibition of Oxidative Phosphorylation Reverses Bone Marrow Hypoxia Visualized in Imageable Syngeneic B-ALL Mouse Model. Frontiers in Oncology 10.
Crossref
Simone Mirabilii, Maria Rosaria Ricciardi & Agostino Tafuri. (2020) mTOR Regulation of Metabolism in Hematologic Malignancies. Cells 9:2, pages 404.
Crossref
Bruno António Cardoso. 2020. Tumor Microenvironment. Tumor Microenvironment 259 293 .
Mateusz Rytelewski, Karine Haryutyunan, Felix Nwajei, Meenakshi Shanmugasundaram, Patrick Wspanialy, M. Anna Zal, Chao-Hsien Chen, Mirna El Khatib, Shane Plunkett, Sergei A. Vinogradov, Marina Konopleva & Tomasz Zal. (2019) Merger of dynamic two-photon and phosphorescence lifetime microscopy reveals dependence of lymphocyte motility on oxygen in solid and hematological tumors. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Fen Zhou, Yuxi Wen, Runming Jin & Hongbo Chen. (2019) New attempts for central nervous infiltration of pediatric acute lymphoblastic leukemia. Cancer and Metastasis Reviews 38:4, pages 657-671.
Crossref
Marilena Ciciarello, Giulia Corradi, Federica Loscocco, Giuseppe Visani, Federica Monaco, Michele Cavo, Antonio Curti & Alessandro Isidori. (2019) The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia. Frontiers in Oncology 9.
Crossref
Andrew Sulaiman, Sarah McGarry, Xianghui Han, Sheng Liu & Lisheng Wang. (2019) CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs. Cancers 11:8, pages 1128.
Crossref
Jérémie Gaudichon, Hélène Jakobczyk, Lydie Debaize, Elie Cousin, Marie-Dominique Galibert, Marie-Bérengère Troadec & Virginie Gandemer. (2019) Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: Reconciling biological concepts and clinical issues. Blood Reviews 36, pages 40-56.
Crossref
Jo Ishizawa, Sarah F. Zarabi, R. Eric Davis, Ondrej Halgas, Takenobu Nii, Yulia Jitkova, Ran Zhao, Jonathan St-Germain, Lauren E. Heese, Grace Egan, Vivian R. Ruvolo, Samir H. Barghout, Yuki Nishida, Rose Hurren, Wencai Ma, Marcela Gronda, Todd Link, Keith Wong, Mark Mabanglo, Kensuke Kojima, Gautam Borthakur, Neil MacLean, Man Chun John Ma, Andrew B. Leber, Mark D. Minden, Walid Houry, Hagop Kantarjian, Martin Stogniew, Brian Raught, Emil F. Pai, Aaron D. Schimmer & Michael Andreeff. (2019) Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality. Cancer Cell 35:5, pages 721-737.e9.
Crossref
Jie Ma, Linhua Ji, Zhanquan Li, Huihui Liu, Chengyu Zhao, Hua Xiong, Shengyan Wang, Ri-Li Ge & Sen Cui. (2019) Downregulation of intrinsic apoptosis pathway in erythroblasts contributes to excessive erythrocytosis of chronic mountain sickness. Blood Cells, Molecules, and Diseases 76, pages 25-31.
Crossref
Michela Colombo, Natalia Platonova, Domenica Giannandrea, Maria Teresa Palano, Andrea Basile & Raffaella Chiaramonte. (2019) Re-establishing Apoptosis Competence in Bone Associated Cancers via Communicative Reprogramming Induced Through Notch Signaling Inhibition. Frontiers in Pharmacology 10.
Crossref
Talia Velasco-Hernandez, Shamit Soneji, Isabel Hidalgo, Eva Erlandsson, Jörg Cammenga & David Bryder. (2019) Hif-1α Deletion May Lead to Adverse Treatment Effect in a Mouse Model of MLL-AF9-Driven AML. Stem Cell Reports 12:1, pages 112-121.
Crossref
Carolina Simioni, Alberto M. Martelli, Giorgio Zauli, Marco Vitale, James A. McCubrey, Silvano Capitani & Luca M. Neri. (2018) Targeting the phosphatidylinositol 3‐kinase/Akt/mechanistic target of rapamycin signaling pathway in B‐lineage acute lymphoblastic leukemia: An update. Journal of Cellular Physiology 233:10, pages 6440-6454.
Crossref
Simone Mirabilii, Maria Ricciardi, Monica Piedimonte, Valentina Gianfelici, Maria Bianchi & Agostino Tafuri. (2018) Biological Aspects of mTOR in Leukemia. International Journal of Molecular Sciences 19:8, pages 2396.
Crossref
Domenico Mastrangelo, Lauretta Massai, Giuseppe Fioritoni, Francesco Lo Coco, Nèlida Noguera & Ugo Testa. 2018. Myeloid Leukemia. Myeloid Leukemia.
Alicia D. Henn, Jessica Garigen, Valentina Cipolla, Sheldon Perry, Lorne Farovitch, Randy Yerden, Martin Stuart Zand & Shannon Hilchey. (2018) Cell culture oxygen levels affect B cell migration through HIF-1a signaling. The Journal of Immunology 200:1_Supplement, pages 48.13-48.13.
Crossref
Xiaoyu Yang, Hubin Yin, Yunzhi Zhang, Xinyuan Li, Hang Tong, Yizhou Zeng, Quan Wang & Weiyang He. (2018) Hypoxia-induced autophagy promotes gemcitabine resistance in human bladder cancer cells through hypoxia-inducible factor 1α activation. International Journal of Oncology.
Crossref
Cecilia Evangelisti, Alessandra Cappellini, Mariana Oliveira, Rita Fragoso, João T. Barata, Alice Bertaina, Franco Locatelli, Carolina Simioni, Luca M. Neri, Francesca Chiarini, Annalisa Lonetti, Francesca Buontempo, Ester Orsini, Andrea Pession, Lucia Manzoli, Alberto Maria Martelli & Camilla Evangelisti. (2018) Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia. Journal of Cellular Physiology 233:3, pages 1796-1811.
Crossref
Pengmu Xie, Hongying Cao, Ying Li, Jianhua Wang & Zhumei Cui. (2017) RETRACTED: Knockdown of lncRNA CCAT2 inhibits endometrial cancer cells growth and metastasis via sponging miR-216b. Cancer Biomarkers 21:1, pages 123-133.
Crossref
Syed Ghulam Musharraf, Amna Jabbar Siddiqui, Tahir Shamsi & Arshi Naz. (2017) SERUM metabolomics of acute lymphoblastic leukaemia and acute myeloid leukaemia for probing biomarker molecules. Hematological Oncology 35:4, pages 769-777.
Crossref
Ji Hae Nahm, Hyungjin Rhee, Haeryoung Kim, Jeong Eun Yoo, Jee San Lee, Youngsic Jeon, Gi Hong Choi & Young Nyun Park. (2017) Increased expression of stemness markers and altered tumor stroma in hepatocellular carcinoma under TACE-induced hypoxia: A biopsy and resection matched study. Oncotarget 8:59, pages 99359-99371.
Crossref
L Schito, S Rey & M Konopleva. (2017) Integration of hypoxic HIF-α signaling in blood cancers. Oncogene 36:38, pages 5331-5340.
Crossref
Xiaoling Qian, Wenxia Xu, Jinye Xu, Qiqi Shi, Jiaqiu Li, Yu Weng, Zhinong Jiang, Lifeng Feng, Xian Wang, Jianwei Zhou & Hongchuan Jin. (2017) Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer. Oncotarget 8:29, pages 47691-47708.
Crossref
A.E. Karnoub. 2017. Mesenchymal Stromal Cells as Tumor Stromal Modulators. Mesenchymal Stromal Cells as Tumor Stromal Modulators 335 368 .
C. Petit, F. Gouel, I. Dubus, C. Heuclin, K. Roget & J. P. Vannier. (2016) Hypoxia promotes chemoresistance in acute lymphoblastic leukemia cell lines by modulating death signaling pathways. BMC Cancer 16:1.
Crossref
Luana Schito & Gregg L. Semenza. (2016) Hypoxia-Inducible Factors: Master Regulators of Cancer Progression. Trends in Cancer 2:12, pages 758-770.
Crossref
Maribel Bruno, Jeffrey Ross & Yue Ge. (2016) Proteomic responses of BEAS-2B cells to nontoxic and toxic chromium: Protein indicators of cytotoxicity conversion. Toxicology Letters 264, pages 59-70.
Crossref
Nicole Degwert, Emily Latuske, Gabi Vohwinkel, Hauke Stamm, Marianne Klokow, Carsten Bokemeyer, Walter Fiedler & Jasmin Wellbrock. (2016) Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia. European Journal of Haematology 97:3, pages 239-244.
Crossref
Talha Badar, Damian R. Handisides, Juliana M. Benito, Mary Ann Richie, Gautam Borthakur, Elias Jabbour, Karine Harutyunyan, Sergej Konoplev, Stefan Faderl, Stew Kroll, Michael Andreeff, Tillman Pearce, Hagop M. Kantarjian, Jorge E. Cortes, Deborah A. Thomas & Marina Konopleva. (2016) Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia. American Journal of Hematology 91:8, pages 800-805.
Crossref
Lihua Xu, Xu Wang, Jiani Wang, Dan Liu, Yaya Wang, Zhenqian Huang & Huo Tan. (2015) Hypoxia-induced secretion of IL-10 from adipose-derived mesenchymal stem cell promotes growth and cancer stem cell properties of Burkitt lymphoma. Tumor Biology 37:6, pages 7835-7842.
Crossref
Sara M. Radwan, Nadia M. Hamdy, Hany M. Hegab & Hala O. El-Mesallamy. (2016) Beclin-1 and hypoxia-inducible factor-1α genes expression: Potential biomarkers in acute leukemia patients. Cancer Biomarkers 16:4, pages 619-626.
Crossref
Juliana Benito, Marc S. Ramirez, Niki Zacharias Millward, Juliana Velez, Karine G. Harutyunyan, Hongbo Lu, Yue-xi Shi, Polina Matre, Rodrigo Jacamo, Helen Ma, Sergej Konoplev, Teresa McQueen, Andrei Volgin, Marina Protopopova, Hong Mu, Jaehyuk Lee, Pratip K. Bhattacharya, Joseph R. Marszalek, R. Eric Davis, James A. Bankson, Jorge E. Cortes, Charles P. Hart, Michael Andreeff & Marina Konopleva. (2016) Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models. Clinical Cancer Research 22:7, pages 1687-1698.
Crossref
Weiguo Zhang, Gautam Borthakur, Chen Gao, Ye Chen, Hong Mu, Vivian R. Ruvolo, Kenichi Nomoto, Nanding Zhao, Marina Konopleva & Michael Andreeff. (2016) The Dual MEK/FLT3 Inhibitor E6201 Exerts Cytotoxic Activity against Acute Myeloid Leukemia Cells Harboring Resistance-Conferring FLT3 Mutations. Cancer Research 76:6, pages 1528-1537.
Crossref
Francesca Chiarini, Annalisa Lonetti, Camilla Evangelisti, Francesca Buontempo, Ester Orsini, Cecilia Evangelisti, Alessandra Cappellini, Luca M. Neri, James A. McCubrey & Alberto M. Martelli. (2016) Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1863:3, pages 449-463.
Crossref
Yang Han, Xidi Wang, Bingping Wang & Guosheng Jiang. (2016) The progress of angiogenic factors in the development of leukemias. Intractable & Rare Diseases Research 5:1, pages 6-16.
Crossref
Donya Moradi Manesh, Jad El-Hoss, Kathryn Evans, Jennifer Richmond, Cara E. Toscan, Lauryn S. Bracken, Ashlee HedrickRosemary Sutton, Glenn M. MarshallWilliam R. WilsonRaushan T. KurmashevaCatherine Billups, Peter J. HoughtonMalcolm A. Smith, Hernan Carol & Richard B. Lock. (2015) AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia. Blood 126:10, pages 1193-1202.
Crossref
Miguel Mendivil-Perez, Carlos Velez-Pardo & Marlene Jimenez-Del-Rio. (2015) Doxorubicin induces apoptosis in Jurkat cells by mitochondria-dependent and mitochondria-independent mechanisms under normoxic and hypoxic conditions. Anti-Cancer Drugs 26:6, pages 583-598.
Crossref
Helena Doktorova, Jan Hrabeta, Mohamed Ashraf Khalil & Tomas Eckschlager. (2015) Hypoxia-induced chemoresistance in cancer cells: The role of not only HIF-1. Biomedical Papers 159:2, pages 166-177.
Crossref
Naval Daver, Yanis Boumber, Hagop Kantarjian, Farhad Ravandi, Jorge Cortes, Michael E. Rytting, Jitesh D. Kawedia, Jordan Basnett, Kirk S. Culotta, Zhihong Zeng, Hongbo Lu, Mary Ann Richie, Rebecca Garris, Lianchun Xiao, Wenbin Liu, Keith A. Baggerly, Elias Jabbour, Susan O'Brien, Jan Burger, Linda J. Bendall, Deborah Thomas & Marina Konopleva. (2015) A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia. Clinical Cancer Research 21:12, pages 2704-2714.
Crossref
Lifang Guo, Yang Chen, Ting He, Feifei Qi, Guanghua Liu, Yan Fu, Chunming Rao, Junzhi Wang & Yongzhang Luo. (2015) Nuclear-translocated endostatin downregulates hypoxia inducible factor-1α activation through interfering with Zn(II) homeostasis. Molecular Medicine Reports.
Crossref
Juliana Benito, Marina Konopleva & William R. Wilson. 2015. Targeted Therapy of Acute Myeloid Leukemia. Targeted Therapy of Acute Myeloid Leukemia 657 679 .
Barbara MuzPilar de la PuenteFeda AzabMicah LudererAbdel Kareem Azab. (2014) The Role of Hypoxia and Exploitation of the Hypoxic Environment in Hematologic Malignancies. Molecular Cancer Research 12:10, pages 1347-1354.
Crossref
Tingyu Wu, Zhongchuan Wang, Yun Liu, Zubing Mei, Guanghui Wang, Zhonglin Liang, Ang Cui, Xuguang Hu, Long Cui, Yili Yang & Chen-Ying Liu. (2014) Interleukin 22 protects colorectal cancer cells from chemotherapy by activating the STAT3 pathway and inducing autocrine expression of interleukin 8. Clinical Immunology 154:2, pages 116-126.
Crossref
Yunnuo Bai, Haitao Zhang, Xiaohan Sun, Changhao Sun & Lihong Ren. (2014) Biomarker identification and pathway analysis by serum metabolomics of childhood acute lymphoblastic leukemia. Clinica Chimica Acta 436, pages 207-216.
Crossref
Yiran Zhang, Kaimin Hu, Yongxian Hu, Lizhen Liu, Binsheng Wang & He Huang. (2014) Bone marrow mesenchymal stromal cells affect the cell cycle arrest effect of genotoxic agents on acute lymphocytic leukemia cells via p21 down-regulation. Annals of Hematology 93:9, pages 1499-1508.
Crossref
Gregg L. Semenza. (2014) Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology. Annual Review of Pathology: Mechanisms of Disease 9:1, pages 47-71.
Crossref
William R. Wilson, Kevin O. Hicks, Jingli Wang & Frederik B. Pruijn. 2014. Hypoxia and Cancer. Hypoxia and Cancer 283 328 .
Scott Portwood, Deepika Lal, Yung-Chun Hsu, Rodrigo Vargas, Megan K. Johnson, Meir Wetzler, Charles P. Hart & Eunice S. Wang. (2013) Activity of the Hypoxia-Activated Prodrug, TH-302, in Preclinical Human Acute Myeloid Leukemia Models. Clinical Cancer Research 19:23, pages 6506-6519.
Crossref
Linhua Jin, Yoko Tabe, Kensuke Kojima, Masato Shikami, Juliana Benito, Vivian Ruvolo, Rui-Yu Wang, Teresa McQueen, Stefan O. Ciurea, Takashi Miida, Michael Andreeff & Marina Konopleva. (2013) PI3K inhibitor GDC-0941 enhances apoptotic effects of BH-3 mimetic ABT-737 in AML cells in the hypoxic bone marrow microenvironment. Journal of Molecular Medicine 91:12, pages 1383-1397.
Crossref
Viviana M. Rodr?guez-Pardo, Jos? A. Aristizabal, Diana Jaimes, Sandra M. Quijano, Iliana de los Reyes, Mar?a Victoria Herrera, Julio Solano & Jean Paul Vernot. (2013) Mesenchymal stem cells promote leukaemic cells aberrant phenotype from B-cell acute lymphoblastic leukaemia. Hematology/Oncology and Stem Cell Therapy 6:3-4, pages 89-100.
Crossref
Juliana Benito, Zhihong Zeng, Marina KonoplevaWilliam R Wilson. (2013) Targeting hypoxia in the leukemia microenvironment. International Journal of Hematologic Oncology 2:4, pages 279-288.
Crossref
Linhua Jin, Yoko Tabe, Hongbo Lu, Gautam Borthakur, Takashi Miida, Hagop Kantarjian, Michael Andreeff & Marina Konopleva. (2013) Mechanisms of apoptosis induction by simultaneous inhibition of PI3K and FLT3-ITD in AML cells in the hypoxic bone marrow microenvironment. Cancer Letters 329:1, pages 45-58.
Crossref
Gaetano Romano. (2013) The Role of the Dysfunctional Akt-Related Pathway in Cancer: Establishment and Maintenance of a Malignant Cell Phenotype, Resistance to Therapy, and Future Strategies for Drug Development. Scientifica 2013, pages 1-12.
Crossref
J. Grassinger & R. Schelker. 2013. Evolution-adjusted Tumor Pathophysiology:. Evolution-adjusted Tumor Pathophysiology: 69 90 .
Ravi Thakur & Durga Prasad Mishra. (2012) Modulation of cell death pathways in cancer stem cells: Targeting histone demethylases. Advances in Bioscience and Biotechnology 03:06, pages 720-730.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.